IVF with HSAs Act of 2024
Latest Action
Read twice and referred to the Committee on Finance.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The IVF with HSAs Act of 2024 is a Senate bill introduced in the 118th Congress that relates to the taxation policy area. The bill's title suggests it involves provisions related to in vitro fertilization (IVF) and Health Savings Accounts (HSAs), potentially allowing or modifying the use of HSAs for IVF-related expenses. However, there is no official summary or full text available, limiting detailed analysis. The bill was read twice and referred to the Senate Committee on Finance but ultimately failed or expired without further legislative action as of January 14, 2025.
This bill aimed to address tax-related aspects of IVF treatments through HSAs but did not advance beyond committee referral and expired without enactment.
- The bill is titled 'IVF with HSAs Act of 2024' and pertains to taxation.
- It was introduced in the Senate during the 118th Congress.
- The bill was read twice and referred to the Committee on Finance but did not progress further and expired.
Potential beneficiaries would have included individuals seeking to use Health Savings Accounts to pay for IVF treatments, as well as healthcare providers and insurers involved in fertility services. The Committee on Finance and tax policy stakeholders would also be relevant parties.
Without the full text, concerns include uncertainty about the bill's specific provisions, potential fiscal impacts on tax revenues, administrative challenges in implementing changes to HSAs, and oversight mechanisms to ensure compliance and proper use of funds.
The bill was introduced in the Senate and referred to the Committee on Finance, a common path for tax-related legislation. Its failure to advance suggests it did not gain sufficient support or priority during the 118th Congress. No further legislative actions were recorded.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
If enacted, the bill could influence the broader use of HSAs for fertility treatments, potentially affecting insurance coverage decisions, healthcare provider billing practices, and patient access to IVF services. It might also set precedents for other medical expense tax treatments.
The absence of an official summary and full bill text limits transparency and public understanding of the bill's specific provisions and impacts. The bill's failure to progress past committee referral further restricts available information. Future legislative proposals on similar topics would benefit from detailed public documentation to facilitate oversight and informed debate.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.